维普中文期刊产品整合服务
17篇 您的检索式:作者名="Nazma"
    题名 作者 年代 出处 被引量
1Trimethyl chitosan and its applications in drug delivery显示文摘Mourya VK Nazma NI 2009J Mater Sci Mater Med2009,20,:1
2Antioxidant capacity and total phenol content of commonly conslmed selected vegetables of Bangladesh显示文摘Sharmin H Nazma S Mohiduzzaman M 2011Malaysian Journal of Nutrition2011,17,3:1
3X-ray diffraction analysis of silicon prepared from rice husk ash显示文摘NAZMA I AKHTER M 1988J Mater Sci1988,23,9:1
4Chitosan-modifications and applications:Opportunities galore显示文摘Mourya V K Nazma N Inamdar 2008Reactive & Functional Polymers2008,6,68:1
5Antioxidant capacity and total phenol content of commonly consumed selected vegetables of Bangladesh显示文摘H Sharmin S Nazma M Mohiduzzaman 2011Malaysian Journal of Nutrition2011,17,3:1
6Presence of heavy metals in fruits and vegetables:Health risk implications in Bangladesh显示文摘Nazma S Nafis M Ishrat N K 2016Chemosphere2016,152,:1
7Chitosan-modifications and applications: Opportunities galore 显示文摘Mourya V K Nazma N lnamdar 2008Reactive & Functional Polymers2008,6,68:1
8Nematic phases in achiral unsymmetrical four-ring bent-core azo compounds possessingstrongly polar cyano and nitro moieties as end substituents: Synthesis and characterization 显示文摘Somen Debnath Golam Mohiuddin Srikanth Turlapat Nazma Begum Dipika Debnath Sarkar V S Nandiraju Rao 2013Dyes and Pigments2013,99,:1
9Trimethyl chitosan and its applications in drug delivery显示文摘V. K. Mourya Nazma N. Inamdar 2009Journal of Materials Science: Materials in Medicine2009,,5:1
10Trimethyl chitosan and its applications in drug delivery显示文摘Mourya V K Nazma N Inamdar 2009Journal of Materials Science Materials in Medicine2009,20,:1
11Trimethyl chitosan and its applications in drug delivery显示文摘V K Mourya Nazma N Inamdar 2009J Mater Sci: Mater Med2009,20,5:1
12Chemically modified chitin and chitosan as biomaterials显示文摘Mourya VK Inamdar Nazma N 2008Reactive & Functional Polymers2008,68,:1
13Chitosan-modifications and applications:Opportunities galore 显示文摘Mourya V K Inamdar Nazma N 2008Reactive and Functional Polymers2008,68,6:1
14Chitosan-modifications and applications: Opportunities galore显示文摘Mourya V K Nazma N Inamdar 2008Reactive & Functional Polymers2008,68,2:1
15Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010显示文摘Joshua A Salomon Theo Vos Daniel R Hogan Michael Gagnon Mohsen Naghavi Ali Mokdad Nazma Begum Razibuzzaman Shah Muhammad Karyana Soewarta Kosen Mario Reyna Farje Gilberto Moncada Arup Dutta Sunil Sazawal Andrew Dyer Jason Seiler Victor Aboyans Lesley Bake 2012The Lancet . 2012 (9859)2012,,9859:1
16Comparative Efficacy and Safety of Two Formulations ofIpratropium Bromide (IB) HFA pMDI in Patients withChronic Obstructive Pulmonary Disease (COPD)显示文摘Ipratropium bromide (IB) is an effective treatment for reversible bronchospasm associated with COPD. Cipla Ltd. hasdeveloped a formulation of lpratropium bromide pMDI (Test IB) which is designed to be equivalent to the originator product Atrovent HFA pMDI (Reference IB) as a cost effective alternative for the treatment of COPD. The objective of the study was to establishnon-inferiority of the Test 1B to Reference 1B in patients with stable COPD. In this multicenter, randomized, double-blind, doubledummy, parallel group study, patients aged 〉 40 years were randomized to receive 2 puffs three times daily (TID) of either the Test IBor Reference IB for 12 weeks. The primary endpoint was the change from pre dose to post dose FEVj at 90 min at the end of 12 weeks.Secondary endpoints included FVC, symptom score, rescue medication use and St. George's Respiratory Questionnaire (SGRQ).Safety and tolerability included evaluation of adverse events (AEs), vital signs assessments, physical examination and any change inconcomitant medications. A total of 395 patients were randomized to either the Test IB (n = 199) or the Reference IB (n = 196); themajority of patients were male with a mean pre-bronchodilator FEV1 (% predicted) of 60%. The per protocol set comprised of 258patients (n = 129 in each treatment group). The mean treatment difference between the Test IB and Reference 1B for the primaryendpoint (mean change in FEV1 from pre-dose to 90 rain post dose at 12 weeks) was -0.003 L and the lower limit of the 95% confidenceinterval (CI) for the difference between the two products was -0.041 Lwhich is greater than the predefined non inferiority limit of-0.100 L. No significant difference was seen between the Test IB and Reference IB for any secondary efficacy variables. The AEprofile was also comparable between the two treatments. The results indicate that the Test 1B (Ipratropium Bromide HFA pMD1, CiplaLtd.) is non inferior to the Reference lB.Rajendra Mehta Salil Bhargava Santhalingam Balamurugan Nazma Morde Juliet Rebello Jaideep Gogtay Geena Malhotra Shrinivas Purandare 2014Journal of Health Science2014,2,12:0
17Composition Dependence and Irradation Effects on Residual Resistivity in Cu-Al Alloys显示文摘Residual electrical resistivity due to short-range order has been calculated for Cu100-xAlx (x=9.13,13.56, 14.5 and 14.76 in at pct) alloys using pseudopotential approach, and the results have been discussed in the light of experimental studies of the local-order structure of these alloys. In case of Cu85.5Al14.5, change in the total residual electrical resistivity due to neutron-irradiation effects has been estimated by including contributions from the short-range order and static atomic displacement correction. Our results show a decrease in the residual resistivity in the irradiated Cu-Al solid solution as compared to the unirradiated sample. This is in accordance with the experimentalM. Sadiq and Nazma Ikram(Centre for Solid State Physics, University of the Punjab, New Campus, Lahore-54590, Pakistan)A. Shaukat(Physics Dept., University of the Punjab, New Campus, Lahore-54590, Pakistan)Farid A. Khwaja(Dept. of Physics, Quaid-e-Azam Uni 1996Journal of Materials Science & Technology1996,12,4:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费